Cancer Biotherapy and Radiopharmaceuticals
Subject Categories
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 110 |
| Total Docs. (3 years) | 259 |
| Total Refs. | 5,419 |
| Total Citations (3 years) | 546 |
| Citable Docs. (3 years) | 254 |
| Citations / Doc. (2 years) | 1.94 |
| Ref. / Doc. | 49.26 |
| % Female | 42.0% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Top 10 Most Cited Articles
Frequently Asked Questions
What is the impact factor of Cancer Biotherapy and Radiopharmaceuticals?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Cancer Biotherapy and Radiopharmaceuticals has an SJR of 0.498 and is ranked Q2.
What is the SJR and quartile of Cancer Biotherapy and Radiopharmaceuticals?
Cancer Biotherapy and Radiopharmaceuticals has an SJR (SCImago Journal Rank) of 0.498 and its best quartile is Q2.
What is the H-index of Cancer Biotherapy and Radiopharmaceuticals?
The H-index of Cancer Biotherapy and Radiopharmaceuticals is 74, meaning 74 of its articles have each been cited at least 74 times.
Is Cancer Biotherapy and Radiopharmaceuticals indexed in Scopus?
Yes. Cancer Biotherapy and Radiopharmaceuticals is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.